Thrombocytopenia treatment in Istanbul — get 3 personalized clinic matches

Prof. Dr. Savash Kansoy has 48 years of experience of experience and has performed 900+ procedures. He founded pediatric bone marrow transplant units. The Johns Hopkins-affiliated, JCI-accredited clinic offers IVIG therapy, which typically costs $2,500–3,800 and includes the medication and a hospital stay. Systemic therapy for severe cases may run $2,800–9,500. Diagnostic consultations start from $210 and a bone marrow biopsy costs around $800–900.

Prof. Dr. Şebnem İzmirlioğlu Günar has 33 years of experience of hematology experience. She works at JCI-accredited Hisar Hospital, which uses the PYXIS medication system. Diagnostics may start from $50 for a complete blood count. A comprehensive thrombocytopenia workup includes genetic testing and a bone marrow biopsy, which typically runs from $2,000 to $2,600.

Prof. Dr. Ali Irfan Emre Tekgunduz brings 26 years of hematology experience and 900+ procedures to this JCI and ISO-accredited hospital. Diagnostic blood analysis starts around $100. A comprehensive workup including genetic NGS-GTC testing typically costs around $11,500. The clinic offers anticoagulant and thrombolytic therapy for thrombotic complications.

Professor Betul Tavil has 29 years of experience of experience in pediatric hematology, having performed 900+ thrombocytopenia procedures. She treats patients at JCI and ISO-accredited Memorial Şişli Hospital, which has a dedicated bone marrow transplant center. A hematology consultation starts from $140. Treatment options range from a $5,000 two-day IV therapy program to a comprehensive care package around $14,500–$15,025 for a 7-day hospital stay with genetic testing and bone marrow studies.

Memorial Ataşehir Hospital specializes in comprehensive care for thrombocytopenia, backed by JCI accreditation for international treatment standards. Prof. Dr. Kamil Yalçın Polat, a distinguished transplant surgeon with 35 years of experience of experience and training at Memorial Sloan Kettering Cancer Center, leads the team, focusing on complex hematologic conditions.